Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Adrian Langleben, Jeffrey G. Supko, Sebastien J. Hotte, Gerald Batist, Hal W. Hirte, Harry Rogoff, Youzhi Li, Wei Li, David Kerstein, David Leggett, Matthew J. Hitron and Chiang Li | ||||||||||||
Title | A dose-escalation phase I study of a first-in-class cancer stemness inhibitor in patients with advanced malignancies | ||||||||||||
|
|||||||||||||
URL | http://meeting.ascopubs.org/cgi/content/abstract/31/15_suppl/2542 | ||||||||||||
Abstract Text | J Clin Oncol (Meeting Abstracts) May 2013 vol. 31 no. 15_suppl 2542 |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|